ReShape Lifesciences Inc. (RSLS) Misses Q1 EPS by 11c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 11/3/2026

1. CRWD
2. REGN
3. LITE
4. AAPL
5. ABBV
6. MRVL
7. CL
8. LYB
9. TFII
10. ORCL

Go back to ReShape Lifesciences Inc. (RSLS) Misses Q1 EPS by 11c

ReShape Lifesciences Announces Record Revenue for First Quarter 2018

May 14, 2018 4:04 PM EDT

SAN CLEMENTE, Calif., May 14, 2018 /PRNewswire/ -- ReShape Lifesciences Inc. (NASDAQ: RSLS), a developer of minimally invasive medical devices to treat obesity and metabolic diseases, today reported financial results for the three months ended March 31, 2018.  

Recent Highlights and Accomplishments

Achieved record revenues of $950 thousand for the first quarter of 2018 Sold 521 ReShape BalloonsTM in the quarter, a 47% increase compared to the fourth quarter of 2017 Placed 61 ReShape vBlocTM units in the first quarter of 2018, as compared to 21 in the fourth quarter of 2017 Signed a... More